Intratumor RNA interference of cell cycle genes slows down tumor progression (Q39578441)

13 September 2017

title

Intratumor RNA interference of cell cycle genes slows down tumor progression (English)

1 reference

13 September 2017

1 reference

1 reference

8

1 reference

13 September 2017

F Palombo

4

0 references

author name string

S Dharmapuri

1

1 reference

13 September 2017

D Peruzzi

2

1 reference

13 September 2017

E Marra

3

1 reference

13 September 2017

A J Bett

5

1 reference

13 September 2017

S R Bartz

6

1 reference

13 September 2017

M Yong

7

1 reference

13 September 2017

N La Monica

9

1 reference

13 September 2017

C A Buser

10

1 reference

13 September 2017

C Toniatti

11

1 reference

13 September 2017

L Aurisicchio

12

1 reference

13 September 2017

publication date

10 March 2011

1 reference

13 September 2017

1 reference

13 September 2017

volume

18

1 reference

13 September 2017

issue

7

1 reference

13 September 2017

page(s)

727-733

1 reference

RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.27

Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.27

RNA interference in adult mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.27

Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.27

An alternative and effective HIV vaccination approach based on inhibition of antigen presentation attenuators in dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.27

Vaccination with dendritic cells transfected with BAK and BAX siRNA enhances antigen-specific immune responses by prolonging dendritic cell life

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.27

In vivo delivery of caspase-8 or Fas siRNA improves the survival of septic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.27

Biodistribution of phosphodiester and phosphorothioate siRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.27

Chemical modification: the key to clinical application of RNA interference?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.27

Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.27

Induction of in vivo synthetic lethal RNAi responses to treat glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.27

pH-triggered release of vancomycin from protein-capped porous silicon films

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.27

Lipid-based nanotherapeutics for siRNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.27

siRNA and the lung: research tool or therapeutic drug?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.27

Evaluation of efficacy, biodistribution, and inflammation for a potent siRNA nanoparticle: effect of dexamethasone co-treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.27

The coagulation cascade in sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.27

Robust hepatic gene silencing for functional studies using helper-dependent adenoviral vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.27

Inhibition of hepatitis C virus infection and expression in vitro and in vivo by recombinant adenovirus expressing short hairpin RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.27

Adenovirus-mediated small hairpin RNA targeting Bcl-XL as therapy for colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.27

Adenovirus-mediated down-regulation of X-linked inhibitor of apoptosis protein inhibits colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.27

Inhibition of renal cancer cell growth in vitro and in vivo with oncolytic adenovirus armed short hairpin RNA targeting Ki-67 encoding mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.27

Progress on kinesin spindle protein inhibitors as anti-cancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.27

Targeted anti-mitotic therapies: can we improve on tubulin agents?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.27

Mitotic drug targets and the development of novel anti-mitotic anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.27

Gene silencing in mammals by small interfering RNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.27

siRNA relieves chronic neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.27

Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.27

Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.27

Recent progress in the identification and clinical evaluation of inhibitors of the mitotic kinesin KSP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.27

Discovery and biochemical characterization of selective ATP competitive inhibitors of the human mitotic kinesin KSP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.27

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.27

BI 2536, a potent and selective inhibitor of polo-like kinase 1, inhibits tumor growth in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.27

Engineered adenovirus serotypes for overcoming anti-vector immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.27

A rapid and easy method for production and selection of recombinant adenovirus genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.27

The design of vectors for RNAi delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.27

inferred from DOI database lookup

7 January 2021

based on heuristic

Rational combinations of siRNAs targeting Plk1 with breast cancer drugs

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.27

inferred from DOI database lookup

7 January 2021

based on heuristic

Adenovirus vector-induced innate inflammatory mediators, MAPK signaling, as well as adaptive immune responses are dependent upon both TLR2 and TLR9 in vivo

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.27

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/GT.2011.27

1 reference

Dimensions Publication ID

13 September 2017

1003609297

0 references

Fatcat ID

release_bwnqrhqmufc3to3ssluro73y7a

0 references

1 reference